Category Press releases

Wilmington PharmaTech Announces $50 Million Expansion to Double U.S. Small-Molecule API Production Capacity in Delaware

Wilmington PharmaTech Announces $50 Million Expansion to Double U.S. Small-Molecule API Production Capacity in Delaware

Wilmington PharmaTech Announces Major Expansion to Strengthen U.S. API Manufacturing Wilmington PharmaTech, a leading U.S.-based contract research, development, and manufacturing organization specializing in complex custom small-molecule active pharmaceutical ingredient production,…

Read MoreWilmington PharmaTech Announces $50 Million Expansion to Double U.S. Small-Molecule API Production Capacity in Delaware